PCM
EVH icon

Penserra Capital Management’s Evolent Health EVH Stock Holding History

Penserra Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-27,081
Closed -$973K – 1166
2022
Q3 		$973K Buy
27,081
+8,218
+44% +$290K 0.03% 369
2022
Q2 		$579K Buy
+18,863
New +$550K 0.02% 454

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Penserra Capital Management's EVH Position: Q4 2022 in Review

Penserra Capital Management sold out of Evolent Health (EVH) in Q4 2022, closing a stake of 27,081 shares — an estimated $973K sold.

Penserra Capital Management first reported a position in EVH in Q2 2022 and held it in 2 quarters. The position peaked at $973K in Q3 2022. 232 funds tracked by Wall St. Rank hold EVH as of Q4 2022.

  • Penserra Capital Management reported no remaining Evolent Health position as of Q4 2022 after selling out during the quarter.
  • Penserra Capital Management sold 27,081 Evolent Health shares in Q4 2022, an estimated $973K.
  • Penserra Capital Management first reported a position in Evolent Health in Q2 2022 and held it in 2 quarters.
  • Penserra Capital Management's Evolent Health position peaked at $973K in Q3 2022.
  • 232 funds tracked by Wall St. Rank held Evolent Health as of Q4 2022.

Based on Penserra Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.